童安莉, 李汉忠. 多发内分泌肿瘤治疗共识与争议[J]. 协和医学杂志, 2020, 11(4): 365-369. DOI: 10.3969/j.issn.1674-9081.2020.04.002
引用本文: 童安莉, 李汉忠. 多发内分泌肿瘤治疗共识与争议[J]. 协和医学杂志, 2020, 11(4): 365-369. DOI: 10.3969/j.issn.1674-9081.2020.04.002
An-li TONG, Han-zhong LI. Consensus and Controversy on the Treatment of Multiple Endocrine Neoplasia[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(4): 365-369. DOI: 10.3969/j.issn.1674-9081.2020.04.002
Citation: An-li TONG, Han-zhong LI. Consensus and Controversy on the Treatment of Multiple Endocrine Neoplasia[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(4): 365-369. DOI: 10.3969/j.issn.1674-9081.2020.04.002

多发内分泌肿瘤治疗共识与争议

Consensus and Controversy on the Treatment of Multiple Endocrine Neoplasia

  • 摘要: 多发内分泌肿瘤(multiple endocrine neoplasia, MEN)是一种累及多种内分泌腺体的常染色体显性遗传病, 常同时或先后发生两种以上内分泌肿瘤。MEN相关肿瘤包括原发性甲状旁腺功能亢进症、嗜铬细胞瘤、甲状腺髓样癌、胰腺神经内分泌肿瘤和垂体瘤等, 这些肿瘤的临床特点和治疗方案与散发性肿瘤比较既有相似之处, 亦有其特殊性。近年来, MEN相关肿瘤的治疗已经达成了一些共识, 但仍存在较多争议, 手术时机及手术切除范围是争议的焦点。

     

    Abstract: Multiple endocrine neoplasia (MEN) is an autosomal dominant hereditary disease involving multiple endocrine glands with two or more endocrine tumors occurring simultaneously or successively. MEN-related tumors include primary hyperparathyroidism, pheochromocytoma, medullary thyroid cancer, pancreatic neuroendocrine neoplasia, and pituitary adenoma, etc. Although the clinical characteristics and treatment of these tumors are similar to those of sporadic tumors, there are differences in some aspects. In recent years, there has been some consensus achieved on the treatment of MEN-related tumors. But there are also some controversies. The timing and scope of surgical resection are the focus of controversies.

     

/

返回文章
返回